Mesothelioma takes between 20 and 50 years to develop. Due to this long latency period, the asbestos-caused cancer affects middle-aged and elderly people most often. If a patient...
Read PostMesothelioma Clinical Trial Recruiting Patients for New Immunotherapy Treatment
By: Devin Golden
September 19, 2019
Immunotherapy drugs are commonplace in mesothelioma clinical trials. However, in many cases, these drugs can’t fight cancer alone. A new Phase 2 pleural mesothelioma clinical...
Read PostMay 23, 2019, is one of the most noteworthy dates in the history of mesothelioma. On that date, the U.S. Food and Drug Administration (FDA) approved a new treatment for pleural...
Read PostThe Phase 3 clinical trial for pleural mesothelioma is now looking for participants. The study is testing the effectiveness of gene therapy, immunotherapy and virotherapy...
Read PostNo two patients have the exact same mesothelioma. That’s an often-used line when specialists talk about treating the disease. If each person’s mesothelioma is unique, then...
Read PostIn the latter half of the 20th century, the general public learned of asbestos’ dangers. They learned the substance is, in fact, a carcinogen, one which can lead to aggressive...
Read PostThere are many types of immunotherapy drugs for treating mesothelioma. Some enhance the body’s immune system so it can more effectively fight diseases. Others prevent the...
Read PostConversation With Peritoneal Mesothelioma Specialist Dr. Shanel Bhagwandin
By: Devin Golden
August 20, 2019
Mesothelioma Guide is dedicated to supporting mesothelioma patients and their families. Our website is a vast resource for people looking to find treatment, financial assistance,...
Read PostThink of T-cells like an animal protecting their territory. They’re the body’s top defense mechanism, effective at evicting intruders. However, they’re often ineffective at...
Read PostAsbestos is a dangerous attacker if only because it infiltrates the body without detection. It’s invisible to the naked eye and is just about everywhere — in homes, schools...
Read Post